Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANZ-3: Once-daily ART in Advanced HIV
NCT00532168Phase 4Completed
- Start
- Sep 2007
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of efavirenz, lopinavir, atazanavir in human immunodeficiency virus type 1 infection (HIV-1). Started Sep 2007; status: completed.
02
Drugs
efavirenzlopinaviratazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00532168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532168.